"Compounded, customized medicines are facing extinction because of FDA regulations. Bioidentical hormones (like estriol and progesterone) and thyroid medications made for vulnerable populations with special needs (such as Breast Cancer patients and people with autism) are on the chopping block. So are intravenous nutrients made for patients who often have an adverse reaction to mass-manufactured drugs, and need a more tailored treatment to boost their immune system and digestive function.
"These customized medicines cut into the profits of pharmaceutical companies, who don’t want the competition.